rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

19 Jul,15:29
2563.25
-1.25 (-0.05%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

3,790 2,564.50 2,582.70 - 2,525.00 2,759.00 - 1,376.50 43,421.46
NSE | BSE

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

19 Jul,15:57
2573.15
9.50 (0.37%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

79,070 2563.65 2,587.00 - 2,541.00 2,760.00 - 1,377.25 202,174,083.00
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Kotak Mahindra...
Kotak Mahindra Bank Q1 Profit Up 2% to Rs 3,520 cr - Business News
Kotak Mahindra Bank reported a 2% rise in net profit to Rs 3,520 crore for the first quarter ended June 2024. Read more about the bank's financial performance.
Jul 20, 2024 16:03
Yes Bank Q1...
Yes Bank Q1 Profit Surges 46.7% on Lower Provisions
Yes Bank's net profit rose 46.7% in Q1 FY25, driven by lower provisions and strong loan growth. Deposits grew over 20%, and the bank targets 16-17% loan growth for FY25.
Jul 20, 2024 15:58
India: Preferred...
India: Preferred Investment Destination - Goyal Appeals to Diaspora
India's Commerce Minister, Piyush Goyal, encourages the Indian diaspora in the US to invest in India, highlighting the country's growth potential and attractive investment climate.
Jul 20, 2024 15:50
Credai Urges Tax...
Credai Urges Tax Breaks for Homebuyers, Affordable Housing Incentives
Credai seeks tax benefits for homebuyers, incentives for builders to construct affordable housing, and streamlined approvals in the upcoming Budget. Read more.
Jul 20, 2024 15:07
HDFC Bank Q1...
HDFC Bank Q1 Profit Surges 33% to Rs 16,474 Cr
HDFC Bank's net profit for the June 2024 quarter soared 33.17% to Rs 16,474.85 crore, driven by strong revenue growth and lower provisions. Read more.
Jul 20, 2024 14:48

More News »

Top News

JK Cement Q1 Profit Surges 67% to Rs 184.82 cr
JK Cement's consolidated net profit rose 67% to Rs 184.82 crore in Q1 FY25, driven by strong performance. Revenue edged up 1.62% to Rs 2,807.57 crore.
Jul 20, 2024 16:06
Kotak Mahindra...
Kotak Mahindra Bank Q1 Profit Up 2% to Rs 3,520 cr - Business News
Kotak Mahindra Bank reported a 2% rise in net profit to Rs 3,520 crore for the first quarter ended June 2024. Read more about the bank's financial performance.
Jul 20, 2024 16:03
Yes Bank Q1...
Yes Bank Q1 Profit Surges 46.7% on Lower Provisions
Yes Bank's net profit rose 46.7% in Q1 FY25, driven by lower provisions and strong loan growth. Deposits grew over 20%, and the bank targets 16-17% loan growth for FY25.
Jul 20, 2024 15:58
India: Preferred...
India: Preferred Investment Destination - Goyal Appeals to Diaspora
India's Commerce Minister, Piyush Goyal, encourages the Indian diaspora in the US to invest in India, highlighting the country's growth potential and attractive investment climate.
Jul 20, 2024 15:50
RBL Bank Q1 Net Profit Jumps 29% to Rs 372 cr
RBL Bank's net profit surged 29% to Rs 372 crore in Q1 FY24, driven by strong loan growth and deposit mobilization. Read more.
Jul 20, 2024 15:20

More Top News »

Report Card

PE Ratios
74.27
EPS (Rs.)
34.51
Sales (Rs. Cr)
910.87
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
320
Return on Average Equity
32.6

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Most Active

  • Change (Rs.)
  •  

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close